For any durable medical equipment supplier, the sight of a thick envelope from a government contractor demanding medical records is a cause for concern. But not all audits are created equal. While many are familiar with Recovery Audit Contractors (RACs), a letter from a Unified Program Integrity Contractor (UPIC) signals a much more serious and potentially threatening investigation. Understanding the unique role and aggressive tactics of UPICs is crucial for survival in today's enforcement-heavy climate.
The UPIC program divides the country into five jurisdictions, each managed by a specific contractor tasked with overseeing program integrity. The Northeastern and Midwestern jurisdictions are both managed by CoventBridge Group. The Western and Southern jurisdictions are handled by Qlarant. For many DME providers, the most significant contractor is Safeguard Services (SGS), which holds the contract for the national jurisdiction specifically covering Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS). Knowing which UPIC operates in your region is important, as it is the entity that will initiate an investigation if your billing data is flagged.
What truly distinguishes a UPIC audit is the power wielded by the contractor. Beyond standard post-payment reviews where they can demand repayment for claims already paid, UPICs have the authority to place a supplier on pre-payment review. This means every claim submitted must be manually reviewed and approved before any payment is made. Even more devastating is their ability to recommend a full payment suspension to CMS. If a UPIC finds credible evidence of fraud, it can request that all Medicare payments to the supplier be halted. This action can starve a business of its cash flow, effectively shutting down operations long before any formal finding of wrongdoing is finalized.
The audit process itself is an intense, high-pressure event. A UPIC will typically demand a substantial number of patient files with a very short turnaround time. The burden of proof falls entirely on the DME supplier to produce flawless documentation for every claim under review. This includes the original physician’s order, detailed clinical notes establishing medical necessity, and indisputable proof of delivery. Any missing or incomplete document can result in a claim denial. If the auditors find a high error rate in the initial sample of claims, they will often extrapolate that error rate across all claims billed over a period of years, leading to a massive and potentially business-ending recoupment demand.
The legal and financial stakes of a UPIC audit are incredibly high, and a swift, strategic response is paramount. Health Law Alliance can assist DME suppliers with navigating every stage of a UPIC audit, from the initial records request to appealing adverse findings. Please schedule a free consultation today to protect your business.
MORE ARTICLES BY CATEGORY
The WISeR Model: A New Era of Prior Authorization and Audit Risks for Wound Care
On January 1, 2026, the Centers for Medicare & Medicaid Services (CMS) officially launched the Wasteful and Inappropriate Service Reduction (WISeR) Model. This initiative is not just another administrative hurdle; it is a technology-driven enforcement overhaul aimed directly at the wound care industry.
Read More >>OMIG Audit Defense New York: What the 2026 Work Plan Means for Providers
Every year, the New York Office of the Medicaid Inspector General (OMIG) releases its Work Plan outlining enforcement priorities. The 2026 plan sends a clear signal that Medicaid providers in New York are entering a far more aggressive enforcement environment.
Read More >>PBM Member Denial Audit Findings: A Growing Threat to Pharmacies
Pharmacies undergoing a Pharmacy Benefit Manager (PBM) audit are typically prepared to address inventory discrepancies and documentation issues. What many are not prepared for, however, is the increasing use of PBM member denial findings, allegations that a patient claims they did not receive and/or did not authorize the dispensing of a medication for which a claim was submitted.
Read More >>From Minor PBM Audit Finding to Major Liability: How Small Issues Trigger Big Consequences
Pharmacies often approach a PBM audit with the understanding that small discrepancies and modest recoupments are simply part of doing business. In today’s enforcement landscape, that assumption is no longer safe.
Read More >>